Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Tonstad

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 14, 2003
[Bupropion as an aid for smoking cessation]Serena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 14, 2004
[New trends in the treatment of obesity]Serena Tonstad
The Journal of Cardiovascular Nursing|February 13, 2007
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonistSerena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 12, 2017
[Statin intolerance]Serena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 25, 2005
[Drugs for smoking cessation]Serena Tonstad
Nature Clinical Practice. Cardiovascular Medicine|July 1, 2006
Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?Serena Tonstad
Evidence-Based Medicine|June 1, 2013
Weight gain does not attenuate cardiovascular benefits of smoking cessationSerena Tonstad
Expert Review of Neurotherapeutics|February 9, 2007
Varenicline for smoking cessationSerena Tonstad
Expert Review of Cardiovascular Therapy|March 20, 2004
Treatment of children with familial hypercholesterolemiaSerena Tonstad
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factorsSerena Tonstad
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 14, 2003
[Bupropion as an aid for smoking cessation]Serena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 14, 2004
[New trends in the treatment of obesity]Serena Tonstad
The Journal of Cardiovascular Nursing|February 13, 2007
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonistSerena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 12, 2017
[Statin intolerance]Serena Tonstad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 25, 2005
[Drugs for smoking cessation]Serena Tonstad
Nature Clinical Practice. Cardiovascular Medicine|July 1, 2006
Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?Serena Tonstad
Evidence-Based Medicine|June 1, 2013
Weight gain does not attenuate cardiovascular benefits of smoking cessationSerena Tonstad
Expert Review of Neurotherapeutics|February 9, 2007
Varenicline for smoking cessationSerena Tonstad
Expert Review of Cardiovascular Therapy|March 20, 2004
Treatment of children with familial hypercholesterolemiaSerena Tonstad
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factorsSerena Tonstad
Pageof 22